| 1 |
34249417 | A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers. | 2021 |
1 |
| 2 |
34873494 | Erratum: A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers. | 2021 |
1 |
| 3 |
29179444 | Mechanism study of isoflavones as an anti-retinoblastoma progression agent. | 2017 Oct 24 |
5 |
| 4 |
23272911 | Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. | 2013 Sep |
2 |
| 5 |
20177775 | Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells. | 2010 Jul |
2 |
| 6 |
19472400 | NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. | 2009 Jul 15 |
1 |
| 7 |
14514441 | Antioxidant and free radical scavenging activity of isoflavone metabolites. | 2003 Sep |
1 |